Researchers have developed a biomarker scoring system based upon the severity of gene overexpression that could be utilized to predict patient response to cancer treatments.
Agilent Technologies Inc. (NYSE: A) recently introduced OneSight, a new software platform designed to help researchers visualize and analyze chromosomal aneuploidies in cell-free DNA sequencing data.
This editorial focuses on the use of artificial microorgans as a significant tool in the assessment of drug toxicity.
This review provides an overview of various metabolomics approaches, which have emerged to explore the metabolism of a number of different microorganisms.
Thomas Payne interviews Chris Molloy, IDBS, about software solutions for pharma R&D.
Combining multiple biomarkers for cardiovascular risk assessment: more is usually better – up to a point
This editorial focuses on the utilisation of multiple biomarkers for cardiovascular risk assessment.
This editorial focuses on the use of archived newborn blood spots as a diagnostic tool, which would aim to reduce mortality/morbidity via prevention.
This Conference Report deals with the topics discussed at The Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy.
This editorial focuses on the challenges that are associated with the identification and validation of clinically useful biomarkers. Additionally, a promising SOMAmer technology to combat these problems is also discussed.
This Conference Report deals with the topics discussed at the 9th International Symposium on Drug Analysis.